Facial side effects from COVID-19 vaccines are rare, but they have been documented across a range of types: temporary facial paralysis, swelling at the site of old cosmetic fillers, herpes zoster flare-ups on the forehead and around the eye, and eye inflammation, among others. A large South Korean study found that the risk of facial palsy increased by roughly 12 percent in the month following vaccination, which sounds alarming until you consider the baseline risk is already very low. For most people, these reactions resolved with treatment or on their own. Still, knowing what has been reported and who is most at risk can help you recognize a problem early and get the right care.
Bell’s Palsy and Facial Nerve Weakness
Bell’s palsy, a sudden weakness or paralysis on one side of the face, has been the most closely watched facial side effect since the earliest vaccine trials. In clinical trials for the mRNA vaccines, a small number of participants developed it, prompting researchers to investigate whether this was coincidence or a genuine signal. A systematic review of case reports found that the average time between vaccination and the onset of facial weakness was about ten days, though it ranged anywhere from one day to nearly seven weeks. The left side of the face was affected more often than the right in reported cases.
A nationwide study in South Korea covering 2021 and 2022 offered the clearest population-level picture. It found that the risk of facial palsy was modestly elevated within the first 28 days after any COVID-19 vaccine dose, with an incidence rate ratio of about 1.12. The increase was seen after the first and second doses, but not after the third. The signal appeared across vaccine platforms: both mRNA vaccines and viral vector vaccines were associated with a small uptick, though the increase was somewhat larger for viral vector vaccines.
That said, a separate systematic review described the overall association between COVID-19 vaccination and Bell’s palsy as “weak,” noting that the evidence largely came from case reports and small case series rather than controlled epidemiological studies. The researchers cautioned that more data with larger sample sizes would be needed to draw firm conclusions.
One leading theory for why this happens involves reactivation of latent viruses. Many people carry dormant herpes simplex virus type 1 in the nerve ganglia near the face. The immune stimulation from a vaccine could, in theory, nudge those viruses back into action, inflaming the facial nerve. Another proposed mechanism is molecular mimicry, where the immune response to the vaccine’s spike protein accidentally targets nerve tissue that resembles the viral antigen.
How COVID Infection Compares
An important piece of context often missing from the conversation is that COVID-19 infection itself carries a higher risk of Bell’s palsy than the vaccines do. A systematic review and meta-analysis published in JAMA Otolaryngology found that Bell’s palsy was roughly three times more common after SARS-CoV-2 infection than after vaccination. The analysis compared outcomes across nearly 3 million infection cases and nearly 38 million vaccination records. So while the vaccine is associated with a small bump in risk, catching the virus unvaccinated appears to pose a substantially greater threat to facial nerve function.
Swelling in People with Dermal Fillers
If you have had hyaluronic acid fillers injected into your face, you should know that a small number of people have experienced delayed swelling at their filler sites after receiving a COVID-19 vaccine. A systematic review analyzing early case literature found 13 reported cases of delayed-type reactions following vaccination. All were in middle-aged women with hyaluronic acid filler in the head and neck area, and none had a known history of allergies. Swelling appeared anywhere from less than one day to ten days after the first or second vaccine dose.
In one case, symptoms appeared suddenly six weeks after a second Pfizer dose, though the reporting physicians acknowledged that other immune triggers could not be fully ruled out. Another case involved a 43-year-old woman who developed a delayed hypersensitivity reaction at her filler sites after both mRNA vaccination and a subsequent COVID-19 infection.
The proposed explanation centers on the biology of where fillers sit in the body. Hyaluronic acid fillers are typically injected into or near adipose tissue, which has a high concentration of ACE-2 receptors. The SARS-CoV-2 spike protein, the very protein the vaccines teach your body to recognize, also interacts with ACE-2 receptors. The theory is that when your immune system ramps up its response to the spike protein, it can trigger inflammation at the filler sites as a kind of collateral reaction. Some researchers have suggested that a short course of ACE inhibitors before vaccination could limit this inflammatory response, though that recommendation has not been adopted as standard practice.
The good news is that these reactions responded well to treatment. Corticosteroids, hyaluronidase (an enzyme that dissolves hyaluronic acid), and the blood-pressure medication lisinopril all seemed to produce good results in managing the swelling. If you have fillers and notice unusual puffiness or tenderness in your face after vaccination, it is worth seeing a dermatologist or your injector promptly rather than waiting it out.
Herpes Zoster Reactivation on the Face
Herpes zoster, commonly known as shingles, is caused by reactivation of the varicella-zoster virus that causes chickenpox. A particularly painful form, herpes zoster ophthalmicus, affects the forehead, scalp, and the skin around the eye, following the path of the ophthalmic branch of the trigeminal nerve. Several case reports have described this occurring after COVID-19 vaccination.
In one report, two otherwise healthy men in their mid-thirties and forties developed herpes zoster ophthalmicus after receiving a live COVID-19 vaccine, one just three days after vaccination and the other 28 days after. In another case, a 74-year-old man developed a vesicular rash on his forehead, scalp, nose, and left upper eyelid along with a severe headache five days after his second dose of the Pfizer mRNA vaccine. His case progressed to include meningitis and later neurotrophic keratitis, a condition where the cornea loses sensation and becomes prone to damage.
The mechanism here is similar to what is suspected with Bell’s palsy. Vaccination generates a robust immune response, which in some individuals may temporarily shift the balance between the immune system and dormant viruses, allowing varicella-zoster virus to reactivate. This has been reported with other vaccines too, not just COVID-19 vaccines, so it is not entirely unique to these shots. But the sheer number of COVID-19 doses administered worldwide made even rare events more visible. If you develop a painful, blistering rash on one side of your face after vaccination, particularly involving the forehead or the area around one eye, seek medical attention quickly. Early antiviral treatment can reduce the severity and the risk of lasting nerve damage.
Eye-Related Symptoms
Beyond herpes zoster ophthalmicus, a broader set of eye complaints has been reported after COVID-19 vaccination. An analysis of the Vaccine Adverse Event Reporting System (VAERS) in the United States found that about a third of reported ocular adverse events involved eyelid swelling, red eyes, or conjunctivitis. Blurred vision accounted for roughly a quarter, and visual impairment made up about a fifth. These are self-reported events, so they do not establish that the vaccine caused them, but the pattern was consistent enough to draw attention.
A separate clinical study documented 12 consecutive patients (15 eyes) who developed scleritis or episcleritis, types of inflammatory eye conditions, after COVID-19 vaccination. The average onset was about two weeks after vaccination, though it ranged from 2 to 30 days. Scleritis causes deep eye pain and redness, while episcleritis is milder and often resolves on its own. Both are treatable with anti-inflammatory medications.
These eye reactions are thought to be driven by the same general mechanism underlying other facial side effects: the vaccine stimulates an immune response that, in susceptible individuals, produces inflammation in tissues that were not the intended target. The eye has a rich blood supply and sits close to immune-active tissues, making it a plausible site for these overflow reactions.
Skin Reactions on the Face
Rosacea-like eruptions are among the less discussed but documented facial skin reactions after COVID-19 vaccination. In one reported case, a 46-year-old man developed itchy, prickling, reddish bumps and pustules on his face about a month after his second Pfizer dose. The lesions improved with treatment but flared again about a month after his third dose, suggesting a repeatable link to the immune stimulus from vaccination. The reporting physicians noted that the exact cause was unclear but believed the immune response triggered by the vaccine played a role.
More broadly, a review of reported orofacial adverse effects of COVID-19 vaccines noted that while reactions affecting the face and mouth were rare, they did include facial swelling and swelling of the lips, face, or tongue in the context of anaphylactic responses. Anaphylaxis itself is extremely rare after COVID-19 vaccination, and facial swelling in that context is part of a systemic allergic reaction rather than a localized facial side effect. The distinction matters because anaphylaxis requires immediate emergency treatment, while localized skin reactions are managed very differently.
Tingling, Numbness, and Sensory Changes
Some people have reported altered sensation in the face after vaccination, including tingling, numbness, and changes in taste. One case report described a patient whose initial symptoms began just five to six hours after vaccination, with tingling and numbness on the tongue and around the mouth along with altered taste. That patient went on to develop bilateral facial nerve palsy, meaning both sides of the face were affected, which is considerably rarer than the typical one-sided Bell’s palsy.
A study of new-onset numbness and tingling (anesthesia and paresthesia) following COVID-19 vaccination in Quebec found that while these sensory symptoms were most common in the upper limbs and also frequent in the lower limbs, the face was involved in roughly 42 percent of reported cases. That is a notable proportion. In one pediatric case, a teenaged boy developed left-sided facial nerve paralysis along with sensory loss across the upper parts of his face three days after a first Pfizer dose. Over six weeks of follow-up, his sensation gradually returned and his facial nerve function improved.
Facial tingling or numbness after vaccination does not automatically mean something serious is happening. Transient paresthesia can occur with many vaccines and often resolves within hours or days. But if numbness persists, worsens, or is accompanied by visible facial drooping, it warrants prompt medical evaluation to rule out Bell’s palsy or other nerve involvement.
Oral and Mucosal Symptoms
Oral lesions, including mouth ulcers, sores on the gums, and mucosal inflammation, have been reported following COVID-19 vaccination. Published literature on managing these lesions exists, though the evidence base remains limited to case reports and small series rather than large epidemiological studies. The connection to vaccination is plausible given that the mouth is a mucosal surface with active immune tissue, and immune stimulation can sometimes manifest as oral inflammation. If you develop unusual mouth sores in the days or weeks after a COVID-19 vaccine, mention the timing to your dentist or doctor, as the treatment approach may differ from that for idiopathic oral lesions.
Why Social Media Can Distort the Picture
Facial side effects are inherently visible and alarming, which makes them prime material for social media amplification. A retrospective analysis of social media posts about COVID-19 vaccine side effects found that most content on platforms like Twitter and Instagram was shared by patients and sources with unclear credentials, and the information was of limited quality. This is not to say the reported experiences are fabricated. People genuinely experienced swelling, rashes, and facial changes, and they understandably shared those experiences. But social media tends to amplify dramatic and unusual outcomes while providing little context about how rare they actually are. A person scrolling through dozens of posts about facial swelling after vaccination can easily come away believing the risk is orders of magnitude higher than it is.
The reality is that billions of COVID-19 vaccine doses have been administered worldwide, and facial side effects remain in the “rare” category. Even the South Korean facial palsy study, which found a statistically significant increase in risk, was describing an absolute risk that remained very small. A 12 percent relative increase in something that almost never happens still means it almost never happens. That said, being rare does not mean being unimportant to the person it happens to, and awareness of these reactions helps both patients and doctors respond quickly when they do occur.
Practical Guidance If You Notice Something
Knowing what to watch for matters more than worrying about it in advance. Here is a rough guide to the facial symptoms that have been reported and what to do about them:
- Facial drooping or weakness: Could indicate Bell’s palsy. See a doctor promptly. Treatment with corticosteroids and antivirals is most effective when started early. Most cases resolve within weeks to months.
- Swelling at a filler site: Contact your dermatologist or the clinician who performed your filler injections. Treatments including corticosteroids and hyaluronidase have been effective.
- Painful blistering rash on one side of the face: Could be herpes zoster reactivation. Antiviral medication should be started as soon as possible, especially if the rash involves the area around the eye.
- Red, painful eyes or eyelid swelling: See an eye doctor if symptoms persist beyond a day or two. Scleritis and episcleritis can be treated but should be evaluated to rule out more serious inflammation.
- Persistent tingling or numbness: Transient sensations are common with many vaccines and usually resolve quickly. Numbness lasting more than a day or accompanied by other neurological symptoms warrants medical evaluation.
- New skin eruptions on the face: A rosacea-like rash or unusual facial breakout appearing within weeks of vaccination is worth mentioning to a dermatologist, particularly if it recurs with subsequent doses.
Who May Be at Higher Risk
Most of the facial side effects discussed here do not appear to target a specific demographic uniformly, but some patterns have emerged from the case literature. For dermal filler reactions, the reported cases have overwhelmingly involved middle-aged women with hyaluronic acid fillers, which likely reflects the demographics of who gets fillers more than a biological susceptibility unique to that group. For herpes zoster reactivation, older adults and those with weakened immune systems are generally more susceptible to shingles, and the same appears to hold after vaccination. The 74-year-old man who developed herpes zoster ophthalmicus with meningitis had a more severe course than the younger patients in other reports.
For Bell’s palsy, both the South Korean population study and the systematic review of case reports included a mix of ages and sexes. The South Korean data showed a signal across vaccine types, with viral vector vaccines carrying a somewhat higher relative risk than mRNA vaccines. People who had Bell’s palsy in the past may have a recurrence risk, though the data on this specific question remain thin. If you have a history of Bell’s palsy, it is reasonable to discuss the timing of vaccination and monitoring with your doctor, though the consensus remains that the benefits of vaccination outweigh these small risks for the vast majority of people.